Medical Marijuana Inc (MJNA)
0.0024
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Medical Marijuana Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2018 | 77.78M |
June 30, 2018 | -3.423M |
March 31, 2018 | -82.09M |
December 31, 2017 | 30.98M |
September 30, 2017 | 153.75M |
June 30, 2017 | 232.64M |
March 31, 2017 | 308.06M |
December 31, 2016 | 204.67M |
September 30, 2016 | 52.05M |
June 30, 2016 | 51.57M |
Date | Value |
---|---|
March 31, 2016 | 44.05M |
December 31, 2015 | 31.66M |
September 30, 2015 | 100.74M |
June 30, 2015 | 99.81M |
March 31, 2015 | 112.20M |
December 31, 2014 | 112.80M |
September 30, 2014 | 4.692M |
June 30, 2014 | 6.086M |
March 31, 2014 | 2.209M |
December 31, 2013 | 8.645M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
Skye Bioscience Inc | 16.44M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |